Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Year: 2019
Type: review
Source: Nature Medicine
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2920068846
